Healthcare
Lupin Limited
NSE: LUPIN | Information Technology
₹2476.0
+3.18% Today
Market Fundamentals
Market Cap
₹113,211 Cr
P/E Ratio
N/A
Dividend Yield
0.00%
52W High
₹N/A
Stock Intelligence & News
NSE Online Announcements•2026-06-03
Natco Pharma Limited
Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection". |SUBJECT: Press Release
Read Full Analysis →Get instant alerts when LUPIN breaks news
Join investors who track Lupin Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for LUPIN?
LUPIN is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Lupin Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding LUPIN to your custom watchlist.